Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
This study has been terminated.
First Posted: November 8, 2007
Last Update Posted: August 23, 2011
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||No date given|
|Primary Completion Date:||June 2009 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||August 19, 2011|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD. Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease. Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):192-9. doi: 10.1097/WAD.0000000000000093.